Effects of oral glutamine supplementation on children with solid tumors receiving chemotherapy

Arzu Okur1, Fatih Süheyl Ezgü, Leyla Tümer

  • 1Department of Pediatric Metabolism and Nutrition, Gazi University Faculty of Medicine, Ankara, Turkey. arzu@okur.net

Insights

Oral glutamine supplementation improved immune and nutritional markers in children with solid tumors undergoing chemotherapy. Glutamine may reduce the need for antibiotics during treatment.

Area of Science:

  • Pediatric Oncology
  • Clinical Nutrition
  • Immunology

Background:

  • Limited data exists on glutamine's role in pediatric cancer patients' immune function.
  • Previous studies suggest glutamine benefits adult cancer patients' immunity.

Purpose of the Study:

  • To investigate the effects of oral glutamine supplementation on pediatric cancer patients undergoing chemotherapy.
  • To assess changes in nutritional and immunological parameters with glutamine support.

Main Methods:

  • 21 children (aged 1-17) with solid tumors received oral glutamine (4 g/m2/day) during chemotherapy.
  • A control group received the same chemotherapy protocol without glutamine.
  • Nutritional and immunological parameters were compared between supplemented and control courses.

Main Results:

  • Significant improvements were observed in certain nutritional and immunological parameters with glutamine supplementation.
  • Glutamine administration appeared to decrease the requirement for antibiotics.
  • No adverse effects were mentioned.

Conclusions:

  • Oral glutamine supplementation shows promise in improving outcomes for children with solid tumors receiving chemotherapy.
  • Further research is warranted to confirm these findings and optimize glutamine's role in pediatric oncology.